Max Horlbeck

Max Horlbeck

Harvard University

H-index: 27

North America-United States

About Max Horlbeck

Max Horlbeck, With an exceptional h-index of 27 and a recent h-index of 27 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Systems Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Single-cell multi-scale footprinting reveals the modular organization of DNA regulatory elements

CRISPRi screens identify the lncRNA, LOUP, as a multifunctional locus regulating macrophage differentiation epigenetically and inflammatory signaling through a short, encoded …

FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancer

Crispr/cas transcriptional modulation

GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion–positive rhabdomyosarcoma

Abstract B021: Long non-coding RNAs that are required for robust cell growth in ewing Sarcoma

Dual genome-wide coding and lncRNA screens in neural induction of induced pluripotent stem cells

Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells

Max Horlbeck Information

University

Position

Boston Children's Hospital

Citations(all)

8832

Citations(since 2020)

6408

Cited By

5214

hIndex(all)

27

hIndex(since 2020)

27

i10Index(all)

30

i10Index(since 2020)

30

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Max Horlbeck Skills & Research Interests

Systems Biology

Top articles of Max Horlbeck

Title

Journal

Author(s)

Publication Date

Single-cell multi-scale footprinting reveals the modular organization of DNA regulatory elements

bioRxiv

Yan Hu

Sai Ma

Vinay K Kartha

Fabiana M Duarte

Max Horlbeck

...

2023/3/29

CRISPRi screens identify the lncRNA, LOUP, as a multifunctional locus regulating macrophage differentiation epigenetically and inflammatory signaling through a short, encoded …

bioRxiv

Haley Halasz

Eric Malekos

Sergio Covarrubias

Samira Yitiz

Christy Montano

...

2023

FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancer

Asmin Tulpule

Shruti Menon

Marcus Breese

Yone Lin

Hannah Allegakoen

...

2023/5/29

Crispr/cas transcriptional modulation

2023/2/9

GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion–positive rhabdomyosarcoma

JCI insight

Jacqueline Morales

David V Allegakoen

José A Garcia

Kristen Kwong

Pushpendra K Sahu

...

2022/12/12

Abstract B021: Long non-coding RNAs that are required for robust cell growth in ewing Sarcoma

Clinical Cancer Research

Marcela C Briones Martin del Campo

Alex Lee

Max Horlbeck

Truc Dinh

Marta Roman-Moreno

...

2022/9/15

Dual genome-wide coding and lncRNA screens in neural induction of induced pluripotent stem cells

Cell genomics

David Wu

Aunoy Poddar

Elpiniki Ninou

Elizabeth Hwang

Mitchel A Cole

...

2022/11/9

Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells

Elife

Maxence Le Vasseur

Jonathan Friedman

Marco Jost

Jiawei Xu

Justin Yamada

...

2021/5/26

Genome-scale perturbation of long noncoding RNA expression using CRISPR interference

Functional Analysis of Long Non-Coding RNAs: Methods and Protocols

S John Liu

Max A Horlbeck

Jonathan S Weissman

Daniel A Lim

2021

Fitness effects of CRISPR/Cas9-targeting of long noncoding RNA genes

Nature biotechnology

Max A Horlbeck

S John Liu

Howard Y Chang

Daniel A Lim

Jonathan S Weissman

2020/5

CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma

Genome biology

S John Liu

Martina Malatesta

Brian V Lien

Parna Saha

Shivani S Thombare

...

2020/12

Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs

Nature biotechnology

Marco Jost

Daniel A Santos

Reuben A Saunders

Max A Horlbeck

John S Hawkins

...

2020/3

Pharmaceutical-grade rigosertib is a microtubule-destabilizing agent

Molecular cell

Marco Jost

Yuwen Chen

Luke A Gilbert

Max A Horlbeck

Lenno Krenning

...

2020/7/2

See List of Professors in Max Horlbeck University(Harvard University)